Bright Perfection Protective Day Cream SPF 50
SPF Moisturizer to Prevent Dark Spots and Melasma
Multi-Protection Anti-Dark Spot Face Moisturizer with SPF 50
The fast-absorbing face cream with SPF targets the root cause of hyperpigmentation: sun damage. Powerful UV filters protect your skin from harmful UVA and UVB rays that can cause an overproduction of melanin, leading to dark spots and other pigmentation changes. Skin-lightening active ingredients like marine exopolysaccharides, low-molecular hyaluronic acid with alpha-linolenic acid and niacinamide help to fade hyperpigmentation, age spots and darkened skin. The cream has a non-greasy, non-sticky texture that is quickly absorbed without leaving a white cast. For a flawless, bright and even skin tone.
Try it yourself and see the difference! Dark spots are reduced by up to 60% after 8 weeks of use*
Treats and prevents dark spots, protects against harmful UV rays and UV-induced skin aging
To ensure optimal sun protection, apply a walnut-sized amount to your face, neck and décolleté in the morning. You can also wear the day cream under your make-up.
This skin-protecting formula is sunscreen and dark spot treatment in one. Sun exposure can not only accelerate the aging process with fine lines and wrinkles, it can also lead to hyperpigmentation and an uneven skin tone. The solution: Our Protective Day Cream is formulated with highly effective UV filters that help to prevent discoloration and dark spots from forming. On top of that, the cream contains marine exopolysaccharides, low-molecular hyaluronic acid with alpha-linolenic acid and skin-brightening niacinamide to gradually lighten existing dark spots over time. Squalane protects the skin from moisture loss, while arginine helps to repair visible skin damage. Antioxidant-rich vitamin E protects the skin from free radical damage and premature skin aging. Suitable for all skin types.
Find more details about our BRIGHT PERFECTION line, key ingredients and relevant test results here: BRIGHT PERFECTION Line Overview.
*In-vivo test: 25 women aged 40-64; application twice daily